LifeTech Scientific (HKSE:01302) 3-Year Book Growth Rate : 8.60% (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific 3-Year Book Growth Rate?

LifeTech Scientific's Book Value per Share for the quarter that ended in Dec. 2024 was HK$0.85.

During the past 12 months, LifeTech Scientific's average Book Value per Share Growth Rate was 1.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 8.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 19.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was 32.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of LifeTech Scientific was 83.00% per year. The lowest was -16.60% per year. And the median was 26.80% per year.

Competitive Comparison of LifeTech Scientific's 3-Year Book Growth Rate

For the Medical Devices subindustry, LifeTech Scientific's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeTech Scientific's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

LifeTech Scientific 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

LifeTech Scientific (HKSE:01302) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

LifeTech Scientific 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeTech Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

81X:Germany

Address

No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063

Website

http://www.lifetechmed.com

LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

Executives

Xie Yuehui	2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited	2101 Beneficial owner
Futu Trustee Limited	2301 Trustee
Xie Yuehui	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Bank Of Communications Trustee Limited	2301 Trustee
Hhlr Fund, L.p.	2101 Beneficial owner
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

LifeTech Scientific Headlines

No Headlines